Official Title
PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis: A Multi-centre Observational Case- Control Study
Brief Summary

Whether the perceived changes in management of Acute Severe Ulcerative Colitis during the COVID pandemic are widespread, and whether they have any impact on patient outcomes

Detailed Description

The study aims to evaluate the process, evaluation and therapy variation in management of
ASUC with reference to 2019 British Society of Gastroenterology guidelines and see whether
there are any differences between ambulatory and hospital management in ASUC. Also to
evaluate the outcomes in ASUC patients managed during the COVID-19 pandemic

Completed
Inflammatory Bowel Diseases
COVID
Eligibility Criteria

Inclusion Criteria:

- Patients aged 16 -100 inclusive

- Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index
managed during the study period

Exclusion Criteria:

- Patients aged 16 -100 inclusive

- Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index
managed during the study period

- Admission for elective colectomy

- Pouch or stoma

Eligibility Gender
All
Eligibility Age
Minimum: 16 Years ~ Maximum: 100 Years
Countries
United Kingdom
Locations

Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust
Hull, United Kingdom

Shaji Sebastian, Principal Investigator
Hull University Teaching Hospitals

Hull University Teaching Hospitals NHS Trust
NCT Number
MeSH Terms
COVID-19
Colitis
Colitis, Ulcerative
Inflammatory Bowel Diseases